The Week That Was, The Week Ahead: Macro and Markets, Feb. 1
TipRanks (Sun, 1-Feb 4:15 AM ET)
Globe Newswire (Fri, 23-Jan 5:25 PM ET)
Globe Newswire (Fri, 23-Jan 4:15 PM ET)
Globe Newswire (Thu, 11-Dec 7:30 AM ET)
Globe Newswire (Mon, 10-Nov 7:00 AM ET)
Market Chameleon (Wed, 17-Sep 4:05 AM ET)
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Roivant Sciences Ltd. - Common Shares trades on the NASDAQ stock market under the symbol ROIV.
As of February 2, 2026, ROIV stock price climbed to $21.67 with 533,359 million shares trading.
ROIV has a beta of 0.78, meaning it tends to be less sensitive to market movements. ROIV has a correlation of 0.23 to the broad based SPY ETF.
ROIV has a market cap of $15.07 billion. This is considered a Large Cap stock.
Last quarter Roivant Sciences Ltd. - Common Shares reported $2 million in Revenue and -$.28 earnings per share. This fell short of revenue expectation by $-5 million and exceeded earnings estimates by $.04.
In the last 3 years, ROIV traded as high as $23.91 and as low as $6.59.
The top ETF exchange traded funds that ROIV belongs to (by Net Assets): VTI, IJH, VB, VBK, XBI.
ROIV has outperformed the market in the last year with a return of +90.6%, while the SPY ETF gained +16.0%. In the last 3 month period, ROIV beat the market returning +10.7%, while SPY returned +2.5%. However, in the most recent 2 weeks ROIV has underperformed the stock market by returning -6.3%, while SPY returned +0.4%.
ROIV support price is $21.15 and resistance is $22.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ROIV shares will trade within this expected range on the day.
